Genotype-Phenotype Analysis in Pediatric Patients with Distal Renal Tubular Acidosis

Eujin Park1, Myung Hyun Cho1, Hye Sun Hyun1

  • 1Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Republic of Korea.

Insights

Genetic mutations in SLC4A1 are the most common cause of distal renal tubular acidosis in Korean children, presenting with later onset and milder symptoms. Long-term monitoring for renal function, hearing, and growth is crucial for affected children.

Area of Science:

  • Pediatric Nephrology
  • Medical Genetics
  • Rare Genetic Disorders

Background:

  • Primary distal renal tubular acidosis (dRTA) is a rare pediatric genetic disorder.
  • Causative mutations identified in SLC4A1, ATP6V1B1, and ATP6V0A4 genes.
  • Understanding genetic prevalence and phenotypic variation is critical for diagnosis and management.

Purpose of the Study:

  • To analyze the prevalence and phenotypic differences of genetic mutations in children diagnosed with dRTA.
  • To identify the most common causative genes in the Korean pediatric population.
  • To correlate genotype with clinical presentation and long-term outcomes.

Main Methods:

  • Genetic testing was performed on 17 children diagnosed with dRTA.
  • Analysis included mutations in the three known causative genes: SLC4A1, ATP6V1B1, and ATP6V0A4.
  • Clinical data including age of onset, metabolic acidosis severity, and long-term complications were collected.

Main Results:

  • Pathogenic mutations were identified in 88.2% of patients, with six novel mutations found.
  • SLC4A1 mutations were most prevalent (58.8%), followed by ATP6V0A4 (17.6%) and ATP6V1B1 (11.8%).
  • SLC4A1 mutations were associated with later onset and less severe acidosis; ATP6V1B1 mutations correlated with sensorineural hearing loss. Nephrocalcinosis occurred in all patients. No genotype-phenotype correlation was observed for long-term prognosis.

Conclusions:

  • SLC4A1 mutations are the predominant cause of dRTA in Korean children.
  • Patients with SLC4A1 mutations experience a later disease onset and milder initial presentation.
  • Long-term surveillance for hearing, renal function, and growth is essential for managing pediatric dRTA patients.
Abstract

Related Concept Videos

Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
895
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
918
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.5K
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334